Shetzline Michael
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Shetzline Michael. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| IRWD | SVP, CMO, Head-Res&Drug | Sale | 41,269 | $1.76 | $72,633 | Feb 10, 2025 |
| IRWD | SVP, CMO, Head-Res&Drug | Award / Grant | 48,224 | — | — | Jan 17, 2025 |
| IRWD | CMO,SVP,Head-Res&Drug | Sale | 16,128 | $6.45 | $104,026 | May 20, 2024 |
| IRWD | CMO,SVP,Head-Res&Drug | Option Exercise | 34,936 | — | — | Mar 8, 2024 |
| IRWD | CMO,SVP,Head-Res&Drug | Award / Grant | 54,427 | — | — | Feb 12, 2024 |
| IRWD | CMO,SVP,Head-Res&Drug | Award / Grant | 57,971 | — | — | Jan 17, 2024 |
| IRWD | CMO,SVP,Head-Res&Drug | Sale | 10,324 | $10.12 | $104,479 | May 22, 2023 |
| IRWD | CMO,SVP,Head-Res&Drug | Award / Grant | 69,869 | — | — | Mar 8, 2023 |
| IRWD | CMO,SVP,Head-Res&Drug | Sale | 2,322 | $11.41 | $26,494 | Feb 27, 2023 |
| IRWD | CMO,SVP,Head-Res&Drug | Award / Grant | 14,663 | — | — | Jan 17, 2023 |
| IRWD | CMO,SVP,Head-Res&Drug | Sale | 7,453 | $11.50 | $85,710 | May 23, 2022 |
| IRWD | CMO,SVP,Head-Res&Drug | Award / Grant | 81,448 | — | — | Mar 2, 2022 |
| IRWD | CMO,SVP,Head-Res&Drug | Sale | 1,367 | $10.77 | $14,723 | Feb 28, 2022 |
| IRWD | CMO,SVP,Head-Res&Drug | Award / Grant | 29,326 | — | — | Jan 19, 2022 |
| IRWD | CMO,SVP,Head-Res&Drug | Sale | 13,776 | $11.58 | $159,526 | Nov 23, 2021 |
| IRWD | CMO, SVP & Head of Drug Devt. | Sale | 2,077 | $12.25 | $25,443 | May 24, 2021 |
| IRWD | CMO, SVP & Head of Drug Devt. | Award / Grant | 38,655 | — | — | Mar 26, 2021 |
| IRWD | CMO, SVP & Head of Drug Devt. | Sale | 1,398 | $9.11 | $12,736 | Feb 26, 2021 |
| IRWD | CMO, SVP & Head of Drug Devt. | Award / Grant | 58,252 | — | — | Feb 22, 2021 |
| IRWD | CMO, SVP & Head of Drug Devt. | Award / Grant | 20,740 | — | — | Apr 24, 2020 |